OMB APPROVAL
OMB Number: 3235-0420
Expires: March 31, 2007
Estimated average burden
hours per response: 1646
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20546
FORM 10-KSB
GENERAL FORM FOR REGISTRATION OF SECURITIES OF
Small Business Issuers
Under Section 12(b) or 12(g) of the Securities Exchange Act of 1934
For the Fiscal Year Ended December 31, 2005
TOTALMED, INC
(Name of Small Business Issuer in its charter)
DELAWARE (State or other jurisdiction of incorporation or organization) | 000-30536 (Commission File No.) | 22-3530573 (I.R.S. Employer Identification Number) |
162 M Homestead Street, Manchester, Connecticut 06040
(Address of principal executive offices) (Zip Code)
Issuer's telephone number (860) 805-0701
Securities to be registered under Section 12(b) of the Act: None
Securities registered under Section 12(g) of the Act: COMMON STOCK, par value $.0001 per share
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes[ ] No [X]
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act.) [X] Yes [ ] No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-B is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-KSB or any amendment to this Form 10-KSB [ X ]
Number of shares of Common Stock outstanding at March 31, 2006: 8,244,041
SEC 2337 (11-04) | Persons who potentially are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1
FORM 10-KSB
TABLE OF CONTENTS
PART I
Item 1 Description of Business
3
Item 2 Description of Property
5
Item 3 Legal Proceedings
5
Item 4 Submission of Matters to a Vote of Security Holders
6
PART II
Item 5 Market for Common Equity and Related Stockholder Matters
6
Item 6 Management's Discussion and Analysis or Plan of Operation
7
Item 7 Financial Statements
7
Item 8 Changes In and Disagreements With Accountants on Accounting and Financial Disclosure
21
Item 8a Controls and Procedures
21
Item 8b Other Information
21
PART III
Item 9 Directors, Executive Officers, Promoters and Control Persons
21
Item 10 Executive Compensation
23
Item 11 Security Ownership of Certain Beneficial Owners and Management
23
Item 12 Certain Relationships and related Transactions
24
Item 13 Exhibits
25
Item 14 Principal Accountant Fees and Services
26
Signatures
27
Certifications
2
PART I
Item 1 -Business
TotalMed, Inc. (f/k/a Fonecash, Inc.) (the "Company") was incorporated under the laws of the State of Delaware on August 7, 1997. We changed our name to TotalMed, Inc. on May 11, 2005. During the fourth quarter of December 2002, the Company began to wind down its operations. This occurred because of management’s inability to raise sufficient funds to finance the continued development of the Company’s business plan.
Until that point the Company had been engaged in the payment processing of transactions for banks and their merchants through its terminals and proprietary system. As part of that operation, the Company was developing a wired and wireless gateway to convert consumers' credit and debit card information collected by mobile merchants into a format that can be processed by banks. The Company intended to act as a payment system service provider between banks, mobile merchants and their customers. The Company intended to charge merchants a fixed transaction fee to process their payments.
Currently, the Company remains in development stage and it has no operating profits to date. With the cessation of its pursuit of the credit card processing business, the Company currently has no business operations. The Company is actively seeking a possible merger candidate in an effort to provide shareholders value.
The Company incurred operating losses of $55,512 during 2005. The Company spent a total of $432,256 on Research and Development from Inception to December 31, 2005. The Company expects its accumulated deficit to grow for the foreseeable future.
The Company's Operations to Date
The Company was developing a system of processing credit cards for an under served community of low volume merchants and in-home salespersons consisting of a fixed wire or wireless terminal and a system of computers, utilizing established communications networks, both wired and wireless, for processing the data from credit and debit cards. The Company ceased this operation during the fourth quarter of 2002.
Currently the Company is seeking merger candidates. It has not yet identified nor negotiated with any candidates.
Employees
The Company has one full time employee.
Sources of Revenues
From inception through December 31, 2005, the Company had revenue of $ 10,840 from sale of its products. Currently we have no source of revenue. If the Company can locate, negotiate and acquire a merger candidate revenue could potentially come from the merger candidates’ business operation.
Additional Risks Factors
An investment in the Company's common stock involves a high degree of risk. Investors should consider the following risk factors and the other information in this registration statement carefully before investing in the Company's common stock. The Company's business and results of operations could be seriously harmed if any of these risks actually happen.
3
The Company's Limited Operating History May Prevent it From Achieving Success.
The Company's inception date was August 1997. It has a limited operating history, which may prevent it from achieving success. The Company's has had limited revenues and it operating profits are unproven. It will encounter challenges and difficulties frequently encountered by early-stage companies in new and rapidly evolving markets. The Company may fail to address any of these challenges and the failure to do so would seriously harm the Company's business and operating results. It has limited insights into trends that may emerge and affect the Company's business.
The Company has Incurred Losses and Expects Future Losses
The Company has experienced operating losses in each period since inception and expects to incur losses in the future. On December 31, 2005, the Company had an accumulated deficit of $5,861,870. The Company expects to increase its operating expenses. As a result, the Company will need to achieve revenues and profits. The Company's failure to achieve revenues would seriously harm the Company's business and operating results. In fact, the Company may not have any revenue growth.
Future Operating Results Will Likely Fluctuate
The Company's quarterly operating results will likely vary significantly in the future. As a result, period-to-period comparisons of the Company's operating results will not be meaningful and should not be relied upon as indicators of the Company's future performance. In the future, the Company's operating results may be below the expectations of securities analysts and investors. The Company's failure to meet these expectations would likely depress the market price of the Company's common stock. To date, the Company has not had sufficient operating results to gauge any period-to-period fluctuations.
The Company Must Retain and Attract Key Personnel
The Company's success depends largely on the skills, experience and performance of the members of its senior management and other key personnel. In the future, the Company's growth will depend upon its ability to attract and retain key management personnel.
Reliance on Key Personnel
The Company considers Abraham Pierce to be a key employee. The loss of his services could seriously harm the Company's business. The loss of its employee will add a significant burden to the Company's future prospects.
Future Sales of Shares Could Affect the Company's Stock Price
If the Company's stockholders sell substantial amounts of the Company's common stock in the public market, the market price of the Company's common stock could fall. Of the Company's outstanding common stock as of December 31, 2005, 19% is eligible for sale in the public market immediately.
Shareholders Will Receive No Dividends
The Company has never paid dividends and has no current plans to do so. Given the Company's financial position, it is unlikely that it will pay any dividends in the foreseeable future. The Company plans instead to retain earnings, if any, to fund internal growth.
4
The Company Needs Future Capital
The Company needs to raise funds, and funds may not be available on favorable terms or at all. Failure to obtain funds on favorable terms could seriously harm the Company's business and operating results. Furthermore, if the Company issues additional equity securities, stockholders will experience dilution, and the new equity securities could have rights senior to those of the holders of the Company's common stock. If the Company cannot raise funds on acceptable terms, it will seriously hamper its growth.
Special Note Regarding Forward-Looking Statements
This document contains forward-looking statements. These statements relate to future events or the Company's future financial performance. In some cases, one can identify forward-looking statements by terminology. For example, "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential", or "continue", or the negative of these terms or other comparable terminology, indicate forward-looking statements. These statements are only predictions. Actual events or results may differ materially. In evaluating these statements, one should specifically consider various factors, including the risks outlined in the Risk Factors section. These factors may cause the Company's actual results to differ materially from any forward-looking statement.
Although it believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, neither the Company nor any other person assumes responsibility for whether the forward-looking statements ultimately prove accurate. The Company will not update any of the forward-looking statements after the date of this registration statement to conform to actual results or to make changes in the Company's expectations that occur after the date this registration statement becomes effective.
Item 2. Properties
The Company owns no property. Currently, the Company's principal office is located at 165 M Homestead Street, Manchester, Connecticut 06040. This space is provided to the Company by its President Abraham Pierce. Mr. Pierce will continue to provide this space for the foreseeable future until a suitable merger candidate can be acquired at which point the Company intends to move its business to the merger candidate’s location.
Item 3. Legal Proceedings
The Company was served with a summons and complaint for failure to pay the monthly payments on its line of credit with Fleet National Bank. Pursuant to the lawsuit, the Company would be liable to Fleet National Bank for the outstanding principal balance of $107,645 plus attorney’s fees. Management has indicated its intentions to defend the action.
On April 8, 2002 the Securities and Exchange Commission filed a complaint alleging that a registration statement and amendments, filed with the Commission by the Company in December 2001, January 2002 and March 2002, and signed by the former president of the Company, Daniel E. Charboneau, contained material misrepresentations and omissions. On January 6, 2004, a United States District Judge from the District of Columbia entered a default judgment against the Company restraining the Company from further violations of Section 17(a) of the Securities Act of 1933, Sections 10(b) and 13a-13 of the Securities Exchange Act of 1934 and Rules 10b-5, 12b-20, 13a-1 and 13a-13 thereunder. As part of this order the Court also ordered penalties and interest in the amount of $110,977.
5
Item 4. Submission of Matters to a Vote of Security Holders.
No matters were submitted to a vote of security holders during the fourth quarter. However, the Company did file notification that the majority of shares entitled to vote, did vote on March 3, 2005, to amend the Certificate of Incorporation of the Company to change the name of the Company to TotalMed, Inc. and to affect a reverse split on the common stock of the Company on a 1 for 20 basis. This was effective on May 11, 2005.
PART II
Item 5 Market for the Registrant's Common Equity and Related Stockholder Matters.
The Company's common stock has traded on the OTC Bulletin Board under the symbol "FCSH" since July 3, 2000. The following table sets forth the high and low closing prices for the common stock for the periods indicated:
High
Low
-------------------------------------------------------------------------------------------------------------
2005
Fourth Quarter
$0.0001
$0.0001
Third Quarter
$0.001
$0.0001
Second Quarter
$0.06
$0.002
First Quarter
$0.04
$0.002
2004
Fourth Quarter
$0.0001
$0.0001
Third Quarter
$0.0002
$0.0001
Second Quarter
$0.005
$0.0001
First Quarter
$0.003
$0.0001
As of December 31, 2005 there were approximately 207 holders of record of the common stock. On December 31, 2005, the closing sales price of the Company's common stock was $0.0001 per share.
The Company has not paid any cash dividends on its Common Stock and does not presently intend to do so. Future dividend policy will be determined by its Board of Directors on the basis of its earnings, capital requirements, financial condition and other factors deemed relevant.
The Company's transfer agent is Manhattan Transfer Registrar Co., P.O. Box 361, Holbrook, New York 11741, (631) 585-7341.
Recent Sales of Unregistered Securities
During the period ended March 30, 2006 the Company issued 2,850,000 shares in partial conversion of various notes payable to several non-affiliated individuals.
During the period ended March 31, 2005, the Company issued 42,500,000 shares of stock to two (2) people/entities. This included 12,500,000 shares that were issued to our President for services valued at $1,250 and 30,000,000 shares issued in conversion of a demand note payable of $9,800. These shares were issued pursuant to Section 4 (2).
During the period ended December 31, 2004, the Company issued 12,500,000 shares to it President and sole officer in lieu of cash compensation. This issuance was valued at $0.0001 per share or $1,250.
6
During the period ended December 31, 2003, the Company issued 40,000,000 shares to its two officers in lieu of cash compensation. This issuance was valued at $0.001 per share or $40,000. These shares were issued pursuant to Section 4 (2).
Item 6 - Management's Discussion and Analysis of Financial Condition and Plan of Operation
General
The Company has had revenues of $10,840 since its inception in August 1997 due to the fact that the Company is in the development stage mode for eight years. The Company had a net loss of $5,861,870 since inception to December 31, 2004. All depreciable assets were written down to $ -0- because such assets would no longer provide a future benefit to the Company. The Company expects its accumulated deficit to grow for the foreseeable future.
For the period ending December 31, 2005 general and administrative expenses were $54,262 as compared to $51,287 for the same period in 2004, representing an increase of $2,975. The increase during the period ending December 31, 2005 was primarily due to the costs associated with the Company maintaining its SEC reporting obligations.
The Company's combined cash and cash equivalents totaled $ 17 for the period ended December 31, 2005 compared to $ 1,192 for the period ending December 31, 2004.
The Company does not expect to generate a positive internal cash flow for at least the foreseeable future. The Company currently has limited internal and external sources of liquidity. At this time the Company has no material commitment for capital expenditures.
Liquidity and Capital Resources
The Company presently has no business operations or activity. It has no cash or cash equivalents. It is actively seeking a potential candidate with whom to merge or acquire.
7
Item 7. Financial Statements
![[totalmedksb2005sec002.gif]](totalmedksb2005sec002.gif)
8
TOTALMED, INC. AND SUBSIDIARIES | |||||
FORMERLY FONECASH, INC. AND SUBSIDIARIES | |||||
(A Development Stage Company) | |||||
Consolidated Balance Sheets | |||||
ASSETS | |||||
*Restated | |||||
December 31, | December 31, | ||||
2005 | 2004 | ||||
Current assets: | |||||
Cash | $ | 17 | $ | 1,192 | |
Loan receivable | -- | 1,200 | |||
Total Current Assets | 17 | 2,392 | |||
Total Assets | $ | 17 | $ | 2,392 | |
LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||
Current liabilities: | |||||
Accounts payable | $ | 491,603 | $ | 456,166 | |
Due to former officer/stockholder | 636,743 | 636,743 | |||
Notes payable | 302,531 | 295,881 | |||
Total Current Liabilities | 1,430,877 | 1,388,790 | |||
Contingencies | |||||
Stockholders' deficit : | |||||
Preferred stock; $.0001 par value; authorized - | |||||
10,000,000 shares; issued - none | -- | -- | |||
Common stock; $.0001 par value; authorized - | |||||
500,000,000 shares; issued and outstanding - | |||||
5,202,890 shares in 2005 and 5,553,704 in 2004 | 520 | 555 | |||
Additional paid-in capital | 4,431,990 | 4,420,905 | |||
Treasury stock, 500 shares at cost | (1,500) | (1,500) | |||
Deficit accumulated during the development stage | (5,861,870) | (5,806,358) | |||
Total Stockholders' (Deficit) | (1,430,860) | (1,386,398) | |||
Total Liabilities and Stockholders' (Deficit) | $ | 17 | $ | 2,392 | |
The accompanying notes are an integral part of these statements.
9
TOTALMED, INC. AND SUBSIDIARIES | ||||||||
FORMERLY FONECASH, INC. AND SUBSIDIARIES | ||||||||
(A Development Stage Company) | ||||||||
Consolidated Statements of Operations | ||||||||
*Restated | Aug. 7, 1997 | |||||||
Year Ended | Year Ended | (Inception) to | ||||||
December 31, | December 31, | December 31, | ||||||
2005 | 2004 | 2005 | ||||||
Revenue: | ||||||||
Sales | $ | -- | $ | -- | $ | 10,840 | ||
Cost of sales | -- | -- | 5,662 | |||||
Gross profit | -- | -- | 5,178 | |||||
Interest income | -- | -- | 5,257 | |||||
Total revenue | -- | -- | 10,435 | |||||
Costs and expenses: | ||||||||
Depreciation | -- | -- | 210,426 | |||||
Amortization | -- | -- | 4,118 | |||||
Research and development, related party | -- | -- | 432,256 | |||||
Officer's compensation | 1,250 | 53,750 | 1,138,320 | |||||
Impairment of investment in related party | -- | -- | 50,000 | |||||
Impairment of investment in subsidiaries | -- | -- | 450,000 | |||||
Loss on disposition of assets | -- | -- | 11,449 | |||||
SEC litigation settlement | -- | -- | 110,977 | |||||
General and administrative | 54,262 | 51,287 | 3,464,759 | |||||
55,512 | 105,037 | 5,872,305 | ||||||
Net loss | $ | (55,512) | $ | (105,037) | $ | (5,861,870) | ||
Basic and diluted loss per common share | $ | (.01) | $ | (.02) | ||||
Weighted average common shares outstanding | 5,069,671 | 5,051,655 | ||||||
The accompanying notes are an integral part of these statements.
10
TOTALMED, INC. AND SUBSIDIARIES | ||||||||||||||||
FORMERLY FONECASH, INC. AND SUBSIDIARIES | ||||||||||||||||
(A Development Stage Company) | ||||||||||||||||
Consolidated Statements of Changes in Stockholders' Equity | ||||||||||||||||
For the Period August 7, 1997 (Inception) to December 31, 2005 | ||||||||||||||||
Deficit | ||||||||||||||||
Accumulated | ||||||||||||||||
Additional | During the | |||||||||||||||
Common Stock | Paid-in | Treasury Stock | Development | |||||||||||||
Shares |
|
| Amount | Capital | Shares |
|
| Amount | Stage | |||||||
|
|
|
|
|
| |||||||||||
Balances, August 7, 1997 (inception) | - | $ | - | $ | - | - | $ | - | $ | - | ||||||
Common stock issued for services | ||||||||||||||||
and costs advanced, valued at | ||||||||||||||||
$.0001 per share | 2,000,000 | 200 | - | - | - | - | ||||||||||
Common stock issued for services, | ||||||||||||||||
valued at $.15 per share | 200,000 | 20 | 29,980 | - | - | - | ||||||||||
Net loss for the period | (61,404) | |||||||||||||||
Balances, December 31, 1997 | 2,200,000 | 220 | 29,980 | - | - | (61,404) | ||||||||||
Sale of common stock ($.4156 per share) | 204,500 | 20 | 84,965 | - | - | - | ||||||||||
Net loss | (95,211) | |||||||||||||||
Balances, December 31, 1998 | 2,404,500 | 240 | 114,945 | - | - | (156,615) | ||||||||||
Sale of common stock ($.7622 per share) | 1,098,505 | 110 | 837,160 | - | - | - | ||||||||||
Services contributed by the | ||||||||||||||||
president of the Company | - | - | 60,000 | - | - | - | ||||||||||
Common stock issued for services, | ||||||||||||||||
valued at $.81 per share | 333,333 | 33 | 269,967 | - | - | - | ||||||||||
Net loss | (785,366) | |||||||||||||||
Balances, December 31, 1999 | 3,836,338 | 383 | 1,282,072 | - | - | (941,981) | ||||||||||
Sale of common stock ($1.25 per share) | 25,000 | 3 | 31,247 | - | - | - | ||||||||||
Common stock issued for services, | ||||||||||||||||
valued at $.11 per share | 1,466,667 | 147 | 157,353 | - | - | - | ||||||||||
Common stock issued for services, | ||||||||||||||||
valued at $.5312 per share | 623,367 | 62 | 331,071 | - | - | - | ||||||||||
Purchase of treasury stock | - | - | - | 500 | (1,500) | - | ||||||||||
Net loss | (897,368) | |||||||||||||||
Balances, December 31, 2000 | 5,951,372 | 595 | 1,801,743 | 500 | (1,500) | (1,839,349) | ||||||||||
The accompanying notes are an integral part of these statements.
11
TOTALMED, INC. AND SUBSIDIARIES | ||||||||||||||||
FORMERLY FONECASH, INC. AND SUBSIDIARIES | ||||||||||||||||
(A Development Stage Company) | ||||||||||||||||
Consolidated Statements of Changes in Stockholders' Equity | ||||||||||||||||
For the Period August 7, 1997 (Inception) to December 31, 2005 | ||||||||||||||||
Deficit | ||||||||||||||||
Accumulated | ||||||||||||||||
Additional | During the | |||||||||||||||
Common Stock | Paid-in | Treasury Stock | Development | |||||||||||||
Shares |
|
| Amount | Capital | Shares |
|
| Amount | Stage | |||||||
|
|
|
|
|
| |||||||||||
Balances, December 31, 2000 | 5,951,372 | 595 | 1,801,743 | 500 | (1,500) | (1,839,349) | ||||||||||
Common stock issued for services, | ||||||||||||||||
valued at $.12 per share | 6,959,708 | 696 | 858,080 | - | - | - | ||||||||||
Sale of common stock ($.017 per share) | 1,087,976 | 109 | 17,891 | - | - | - | ||||||||||
Common stock issued in acquisition | ||||||||||||||||
of subsidiaries, valued at $.50 per share | 900,000 | 90 | 449,910 | - | - | - | ||||||||||
Net loss | (1,878,498) | |||||||||||||||
Balances, December 31, 2001 | 14,899,056 | 1,490 | 3,127,624 | 500 | (1,500) | (3,717,847) | ||||||||||
Sale of common stock ($.012 per share) | 10,746,826 | 1,074 | 122,878 | - | - | - | ||||||||||
Common stock issued for services, | ||||||||||||||||
valued at $.03 per share | 32,928,174 | 3,293 | 1,123,851 | - | - | - | ||||||||||
Net loss | (1,857,167) | |||||||||||||||
RESTATED FROM THIS POINT FORWARD | ||||||||||||||||
Balances, December 31, 2002 | 2,928,704 | 293 | 4,379,917 | 500 | (1,500) | (5,575,014) | ||||||||||
Common stock issued for services, | 850,000 | 85 | 16,915 | - | - | - | ||||||||||
valued at $.001 per share | ||||||||||||||||
Common stock issued as repayment of | 1,150,000 | 115 | 22,885 | - | - | - | ||||||||||
related party debt | ||||||||||||||||
valued at $.001 per share | ||||||||||||||||
Net loss | (126,307) | |||||||||||||||
Balances, December 31, 2003 | 4,928,704 | 493 | 4,419,717 | 500 | (1,500) | (5,701,321) | ||||||||||
Common stock issued for services, | 625,000 | 63 | 1,188 | - | - | - | ||||||||||
valued at $.0001 per share | ||||||||||||||||
Net loss | (105,037) | |||||||||||||||
Balances, December 31, 2004 | 5,553,704 | 555 | 4,420,905 | 500 | (1,500) | (5,806,358) | ||||||||||
Common stock issued for services, | 625,000 | 63 | 1,188 | - | - | - | ||||||||||
valued at $.0001 per share | ||||||||||||||||
Common stock issued as repayment of | 1,500,000 | 150 | 9,650 | - | - | - | ||||||||||
debt, valued at $.003 per share | ||||||||||||||||
Common stock retired | (2,475,819) | (248) | 247 | - | - | - | ||||||||||
Additional shares due to stock split | 6 | - | - | - | ||||||||||||
Net loss |
|
|
|
|
| (55,512) | ||||||||||
Balances, December 31, 2005 | 5,202,891 | $ | 520 | $ | 4,431,990 | 500 | $ | (1,500) | $ | (5,861,870) | ||||||
The accompanying notes are an integral part of these statements.
12
TOTALMED, INC. AND SUBSIDIARIES | ||||||||
FORMERLY FONECASH, INC. AND SUBSIDIARIES | ||||||||
(A Development Stage Company) | ||||||||
Consolidated Statements of Cash Flows | ||||||||
*Restated | Aug. 7, 1997 | |||||||
Year Ended | Year Ended | (Inception) to | ||||||
December 31, | December 31, | December 31, | ||||||
2005 | 2004 | 2005 | ||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (55,512) | $ | (105,037) | $ | (5,861,870) | ||
Adjustments to reconcile net loss to net | ||||||||
cash used in operating activities | ||||||||
Depreciation | -- | -- | 210,426 | |||||
Amortization | -- | -- | 4,118 | |||||
Common stock issued for services | 1,250 | 1,250 | 2,854,253 | |||||
Common stock issued in acquisition of subsidiaries | -- | -- | 450,000 | |||||
Common stock issued to an officer in payment of debt | -- | -- | 23,000 | |||||
Notes issued for payment of expenses | 6,250 | -- | 47,530 | |||||
Write-down of lost inventory | -- | -- | 204,338 | |||||
Write off uncollectible accounts | -- | -- | 10,840 | |||||
Loss on disposition of assets | -- | -- | 11,449 | |||||
Changes in assets and liabilities | ||||||||
Increase in accounts receivable | -- | -- | (10,840) | |||||
(Increase) decrease in inventory | -- | -- | (204,338) | |||||
Increase in accounts payable | 35,437 | 10,679 | 491,603 | |||||
Net cash used in operating activities | (12,575) | (93,108) | (1,769,491) | |||||
Cash flows from investing activities: | ||||||||
Payments on notes receivable | -- | (1,200) | (1,200) | |||||
Repayments of notes receivable | 1,200 | -- | 1,200 | |||||
Organization costs | -- | -- | (368) | |||||
Purchases of property and equipment | -- | -- | (220,625) | |||||
Acquisition of patent rights | -- | -- | (5,000) | |||||
Net cash provided by (used in) investing activities | 1,200 | (1,200) | (225,993) | |||||
Cash flows from financing activities: | ||||||||
Proceeds from short-term debt | 10,200 | 43,000 | 328,149 | |||||
Repayment of short-term debt | -- | -- | (63,348) | |||||
Increase in amounts | ||||||||
due to an officer/stockholder | -- | 52,500 | 636,743 | |||||
Purchase of treasury stock | -- | -- | (1,500) | |||||
Proceeds from sale of common stock | -- | -- | 1,095,457 | |||||
Net cash provided by financing activities | 10,200 | 95,500 | 1,995,501 | |||||
Net increase (decrease) in cash | (1,175) | 1,192 | 17 | |||||
Cash at beginning of year | 1,192 | -- | -- | |||||
Cash at end of year | $ | 17 | $ | 1,192 | $ | 17 | ||
Supplemental Cash Flow Information: | ||||||||
Short-term debt converted to stock | 9,800 | -- | ||||||
The accompanying notes are an integral part of these statements.
13
TOTALMED, INC. AND SUBSIDIARIES
(FORMERLY FONECASH, INC. AND SUBSIDIARIES)
(A Development Stage Company)
Notes to Consolidated Financial Statements
Note 1 - Summary of Significant Accounting Policies
Description of Business and Basis of Presentation
The financial statements presented are those of TotalMed, Inc. and its subsidiaries, a development stage company (the “Company”). The Company was incorporated under the laws of the State of Delaware on August 7, 1997. The Company's activities during the year ended December 31, 2005 have been primarily directed towards the raising of capital. The Company’s business activity was to acquire the rights to market an electronic terminal that was to be used by retail merchants and in-home salespersons when payment was made with a credit or debit card. Currently the company is seeking a merger candidate.
The Company has limited operations and in accordance with Statement of Financial Accounting Standards No. 7 (SFAS #7), the Company is considered a development stage company.
Business Combination
On April 10, 2001, pursuant to an agreement with Richwoodland Profits Corporation (“RPC”) and Universal Venture Limited (“UVL”), each a British Virgin Island holding company, the Company has acquired all of the voting stock of four foreign companies that were wholly-owned by RPC and UVL in return for 900,000 shares of common stock of the Company, valued at $.50 per share. The companies acquired are start-up companies that have no assets, liabilities, revenue, expenses and results of operations. The investment in the companies has been reported entirely as goodwill, as there is no value in the companies. The four acquired companies are Universal Information Technology, (Hong Kong) Limited, a company which has developed a video compression technology for Internet and wireless applications; Firstech Ventures (Hong Kong) Limited, a company that locates engineering services for environmental projects in China, especially land fill projects, waste water and waste oil treatment facilities, and waste liner projects; Tech Unity Technology, (Hong Kong) Limited, which engages in gathering information and research about business opportunities in China for dissemination among U.S. and Australian bidders; and Fonecash.com (Hong Kong) Limited, a company engaged in the wireless processing of credit and debit cards for the mobile merchants. In July 2001, the FASB issued Statement No. 141, Business Combinations, and Statement No. 142, Goodwill and Other Intangible Assets. Statement 141 requires that the purchase method of accounting be used for all business combinations initiated or completed after June 30, 2001. Statement 141 also specifies criteria intangible assets acquired in a purchase business combination must meet to be recognized and reported apart from goodwill. The Company has adopted the provisions of Statement 141 in reporting the business combination. Statement 142 requires that goodwill and intangible assets with indefinite useful lives no longer be amortized, but
14
TOTALMED, INC. AND SUBSIDIARIES
(FORMERLY FONECASH, INC. AND SUBSIDIARIES)
(A Development Stage Company)
Notes to Consolidated Financial Statements
Business Combination (Cont’d)
instead tested for impairment at least annually. Statement 142 also requires that intangible assets with definite useful lives be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment in accordance with Statement 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of. Furthermore, any goodwill and any intangible asset determined to have an indefinite useful life that are acquired in a purchase business combination completed after June 30, 2001 will not be amortized, but will continue to be evaluated for impairment in accordance with the appropriate pre- Statement 142 accounting literature. The Company has adopted the provisions of Statement 142 and has written the goodwill associated with the business combination down to zero, as no future benefit can be determined. An impairment loss of $450,000 has been reflected in the consolidated statements of operations.
Use of Estimates in the Preparation of Financial Statements
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reporting amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.
Cash and Cash Equivalents
For purposes of reporting cash flows, cash and cash equivalents include checking and money market accounts and any highly liquid debt instruments purchased with a maturity of three months or less.
Fair Value of Financial Instruments
The fair value of the Company’s payables due to a former officer/stockholder is not practicable to estimate due to the related party nature of the underlying transactions and the indefinite payment terms.
Loss Per Common Share
Loss per common share is computed by dividing the net loss by the weighted average shares outstanding during the year.
15
TOTALMED, INC. AND SUBSIDIARIES
(FORMERLY FONECASH, INC. AND SUBSIDIARIES)
(A Development Stage Company)
Notes to Consolidated Financial Statements
Note 2 - Stockholders' Equity (Deficit)
Common Stock
Two former directors of the company returned 49,516,387 shares of stock to the company. On May 11, 2005 there was a reverse stock split of the common stock of the Company on the basis of one share for each 20 shares outstanding with shareholders of record as of March 1, 2005. The number of common shares outstanding as a result of the reverse stock split was 5,202,890. The December 31, 2004 Common Stock and Additional Paid in Capital balances were restated to reflect the reverse stock split.
On March 1, 2005, prior to the reverse stock split, the loan balance payable to Public Entity Acquisition Corp. (“PEAC”) of $9,800 then outstanding was converted to 30,000,000 shares of common stock of the Company, valued at $.0003 per share.
During the years ended December 31, 2005 and 2004, the Company had issued in each period, 12,500,000 shares of common stock to an officer for compensation, valued at $.0001 per share.
Dividends may be paid on outstanding shares as declared by the Board of Directors from time to time. Each share of common stock is entitled to one vote.
Stock Options
At December 31, 2001 the Company reserved and granted 800,000 shares of common stock for issuance in connection with the stock option plan at an exercise price of $.50 per share. No options have been exercised as of December 31, 2005.
Preferred Stock
No shares of the Company’s preferred stock have been issued or are outstanding. Dividends, voting rights and other terms, rights and preferences of the preferred shares have not been designated but may be designated by the Board of Directors from time to time.
Note 3 - Income Taxes
There is no provision for income taxes since the Company has incurred net operating losses. At December 31, 2005, the Company has net operating loss carryforwards which may be available to offset future taxable income through 2024 in the amount of $5,314,911. A deferred tax asset has not been recorded for the net operating loss carryforwards due to uncertainties as to the ultimate realization of the deferred tax asset. The tax returns of the Company have not been filed.
16
TOTALMED, INC. AND SUBSIDIARIES
(FORMERLY FONECASH, INC. AND SUBSIDIARIES)
(A Development Stage Company)
Notes to Consolidated Financial Statements
Note 4 – Loan Receivable
The Company provided a loan of $1,200 at a rate of 6% to International Commerce Development Corp. (“ICDC”) on October 25, 2004. The loan was repaid on May 25, 2005. Interest income has not been reported in the statements of operations for the years ended December 31, 2005 and 2004 due to its immateriality.
Note 5 – Notes Payable
Notes payable totaling $302,531 and $295,881 consisted of the following at December 31, 2005 and 2004, respectively:
Line of credit with Fleet Bank in the amount of $107,645, unsecured, guaranteed by the president of the Company, interest at 2.75% above prime, monthly payments equal to 2% of principal balance, was due November 2001. The Company is in default with respect to the terms of this note. Legal action has been taken by the bank as of the date of this report.
An SBA note payable in the amount of $6,492 to Habib American Bank, unsecured, interest at 2.75% above prime, payable at $1,604 per month including interest, was due September 1, 2002.
A demand note payable in the amount of $108,744 to J.P. Charboneau, son of former CEO, with interest at 8 % (consists primarily of credit card charges).
A demand note payable in the amount of $30,000 to an individual, unsecured, with interest at 8%, due August 12, 2003. The Company is in default with respect to the terms of this note. No legal action has been taken by the noteholder as of the date of this report.
A demand note payable in the amount of $25,000 to an individual, unsecured, with interest at 6%, due March 24, 2005. The Company is in default with respect to the terms of this note. No legal action has been taken by the noteholder as of the date of this report.
A demand note payable in the amount of $10,000 to an individual, unsecured, with interest at 6%, due March 24, 2005. The Company is in default with respect to the terms of this note. No legal action has been taken by the noteholder as of the date of this report.
Four demand notes payable totaling $14,650 to Public Entity Acquisition Corp. (“PEAC”), unsecured, with interest at 6%, due at various dates in 2006.
Interest expense on notes payable of $25,595 and $20,149 was charged to operations for the years ended December 31, 2005 and 2004, respectively.
These notes payable, excluding Habib Bank and Fleet Bank, are convertible into stock of the Company at the discretion of the Company. At December 31, 2005, the conversion rate was $0.10 per share. On January 16, 2006 the Board of Directors of the Company voted to reduce the conversion rat of these notes payable to $0.02 per share.
17
TOTALMED, INC. AND SUBSIDIARIES
(FORMERLY FONECASH, INC. AND SUBSIDIARIES)
(A Development Stage Company)
Notes to Consolidated Financial Statements
Note 6 - Going Concern
The Company’s consolidated financial statements have been prepared in conformity with principles of accounting applicable to a going concern. These principles contemplate the realization of assets and liquidation of liabilities in the normal course of business. As shown in the consolidated financial statements, the Company has incurred significant net Losses and as of December 31, 2005, reflects a deficit accumulated during the development stage of $5,861,870. The Company has not commenced its planned principal operations. The Company’s continued existence is dependent on its ability to generate sufficient cash flow or raise additional capital to meet its obligations on a timely basis. The Company has been exploring sources to obtain additional equity or debt financing. Without realization of additional capital, it would be unlikely for the Company to continue as a going concern. Accordingly, the Company’s continuation as a going concern is in substantial doubt and the financial statements do not include any adjustments that might be necessary should the Company be unable to continue in existence.
Note 7 – Litigation
The Company was served with a summons and complaint for failure to pay the monthly payments on its line of credit with Fleet National Bank. Pursuant to the lawsuit, the Company would be liable to Fleet National Bank for the outstanding principal balance of $107,645 plus attorney’s fees. Management has indicated its intentions to defend the action and will repay the principal balance in monthly installments upon receipt of capital contributions from investors.
On April 8, 2002 the Securities and Exchange Commission filed a complaint alleging that a registration statement and amendments, filed with the Commission by the Company in December 2001, January 2002 and March 2002, and signed by the president of the Company, Daniel E. Charboneau, contained material misrepresentations and omissions. On January 6, 2004, a United States District Judge from the District of Columbia entered a default judgment against the Company restraining the Company from further violations of Section 17(a) of the Securities Act of 1933, Sections 10(b) and 13a-13 of the Securities Exchange Act of 1934 and Rules 10b-5, 12b-20, 13a-1 and 13a-13 thereunder. As part of this order the Court also ordered penalties and interest in the amount of $110,977.
18
TOTALMED, INC. AND SUBSIDIARIES
(FORMERLY FONECASH, INC. AND SUBSIDIARIES)
(A Development Stage Company)
Notes to Consolidated Financial Statements
Note 8 - Related Party Transactions
The Company was indebted to former officers/stockholders in the amount of $636,743 as of December 31, 2005, which includes $424,281 for unpaid salary, $58,200 for research and development expenses, as discussed below, and $154,262 for merchandise purchases and expenses advanced on behalf of the Company. There are no specific terms for repayment. There is also $167,950 owed to Advance Data Information Corporation (“ADI”), a Taiwan corporation owned by a former director/stockholder of the Company for purchases made by the Company. At December 31, 2005, the conversion rate was $0.10 per share. On January 16, 2006 the Board of Directors of the Company voted to reduce the conversion rate of these notes payable to $0.02 per share.
The Company had leased its executive offices and storage facilities from the former president of the Company under a month-to-month operating lease since the Company’s inception. Rent expense was $0 for the years ended December 31, 2005 and 2004, respectively.
Note 9- Consulting Agreements
The Company entered into a consulting agreement with Advance Data Information Corporation ("ADI"), a Taiwan corporation owned by Dr. Wu, a director/stockholder of the Company, in which ADI will act as the research and development laboratory for the Company. The Company shall have exclusive ownership rights to any and all products that are developed as a result of this agreement. The Company issued 200,000 shares of its common stock to Dr. Wu in August 1997, valued at $.15 per share; 333,333 shares in June 1999, valued at $.81 per share; 1,466,667 shares in December 2000, valued at $.11 per share; 2,400,000 shares in March 2002, valued at $.04; and 17,000,000 shares in June 2003, valued at $.001 for services rendered. On February 1, 2005, all of these shares were returned to the Company and retired to treasury as unissued.
Note 10 – Commitments and Contingencies
The Company provides accruals for all direct costs associated with the estimated resolution of contingencies at the earliest date at which it is deemed probable that a liability has been incurred and the amount of such liability can be reasonably estimated.
Note 11 – Subsequent Events
On January 16, 2005 the Board of Directors of the Company voted to reduce the conversion rate of the convertible notes payable from $0.10 per share to $0.02 per share. The Company will recognize the effects of this Beneficial Conversion Feature in its 10-QSB for the period ending March 31, 2006 as an increase to interest expense.
19
TOTALMED, INC. AND SUBSIDIARIES
(FORMERLY FONECASH, INC. AND SUBSIDIARIES)
(A Development Stage Company)
Notes to Consolidated Financial Statements
Note 11 – Subsequent Events (continued):
On February 9, 2006, the Company issued 2,850,000 shares of common stock in partial conversion of various convertible notes payable. These shares were issued through an exemption under Section 4(2) to non affiliated persons.
20
Item 8. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
NONE.
Item 8A. Controls and Procedures
The Registrant’s President (who is also the Principal Accounting Officer) has evaluated the Company’s disclosure controls and procedures within 90 days of the filing date of this annual report. Based upon this evaluation, he has concluded that the Company’s disclosure controls and procedures are effective in ensuring that material information required to be disclosed is included in the reports that it files with the Securities and Exchange Commission.
Item 8B. Other Information
NONE.
PART III
Item 9 - Directors and Executive Officers
A) Current
Name
Age
Position
-----------------------------------------------------------------------------------------------------------------------------
Abraham Pierce
29
President/Chairman
All current directors were appointed to their office in November of 2004 and will hold office until the next annual stockholders' meeting and until their successors have been elected or qualified or until their death, resignation, retirement, removal, or disqualification. Vacancies on the board will be filled by a majority vote of the remaining directors. Officers of the Company serve at the discretion of the Board of Directors.
The Company's management comprises:
Abraham Pierce, President and Chairman:
Abraham Pierce joined the Company in July of 2004. He is a freelance computer consultant and multimedia designer in the Greater Hartford, CT area. In November of 2000, Mr. Pierce began his consultancy. His clients have included the University of Hartford, the New England Laborers Training Academy, and Phoenix Investment Partners. Mr. Pierce has more than four years of experience as a computer trainer. He also holds a BFA from the University of Hartford with double majors in photography and printmaking. From 1997 to 2000 Mr. Pierce was shift manager for Harry's Pizza in West Hartford, CT.
All of the following individuals were involved in the Company during the time period covered by this report. All of these individuals have resigned from their respective positions.
Daniel E. Charboneau, Former CEO/President/Chairman of the Board:
Mr. Charboneau resigned effective January 2004. He is an experienced management executive with over twenty years of accomplishments in the area of marketing, sales, organizational development, manufacturing and profit-center responsibilities. He has worked with several multi-national companies, including Bechtel International where he was Organization Development Consultant from 1974 to 1980, and with 3M in Asia from 1980 to 1984. From 1984 to 1987, Mr. Charboneau operated as a consultant to U.S. and European businesses who were interested in investment in Asia.
21
In 1987, in a joint venture with A&H, a jewelry maker in Rhode Island, Mr. Charboneau established a manufacturing plant in Taiwan whose products were exported worldwide. In addition to his duties on the Board of Directors, Mr. Charboneau directs the development of technologies, products, markets and manages business relations with Asian suppliers.
John Jiann-Shong Wu, Former Director and Co-founder:
Mr. Wu resigned effective July 2004. Born in China, Dr. Wu became an American citizen in 1978. Educated in Taiwan, Dr. Wu received his Master Degree in Computer Science from Florida Institute of Technology and his doctorate in Electrical Engineering from Leland Stanford Junior University. From 1975 to 1982 he was a Researcher with Taiwan National Science, and from 1982 to 1988 a Senior Engineer and Project Manager with General Electric Company in Singapore. From 1989 to 1990, he was a Project Manager with Digital Equipment Corporation and from 1990 to 1991 he was Senior Consulting Engineer with Hewlett Packard. Dr. Wu has designed many products, both hardware and software, and founded his R&D facility to promote better design of electrical and telephonic products. From 1991 to 1996, Dr. Wu was co-founder and Vice President of V-Star Electronics, then, from 1997 until present, Dr. Wu started his own advanced laboratory, Advance Data Information and became a co-founder in FoneCash.
Daniel S. MacDonald, Director
Mr. MacDonald resigned effective July 2004. Mr. MacDonald has 22 years of experience in the mutual fund industry and is a Certified Financial Planner and holds licenses in real estate, insurance and securities. He resided in Japan for from 1962 to 1972 as International Liaison for the Japanese Chamber of Commerce; he speaks Japanese fluently. From 1972 to 1986, he serves in various capacities with Oppenheimer Management Corporation, first in San Francisco as Regional Sales Manager and ending in New York as Senior Vice President and National Sales Manager. In 1989, Mr. MacDonald started MDIC, Inc. in Bronxville, New York, and for the last 11 years until present, remains as owner and manager of this financial services corporation specializing in mutual funds.
Michael Wong. Director and Chief Financial Officer:
Mr. Wong resigned effective July 2004. Born in Malaysia in 1965, he grew up in Singapore. Mr. Wong is a financial management professional, who received his higher education in Great Britain and received his BA in Accounting and Finance in 1991. Upon returning to Singapore, he joined Price Waterhouse as a tax accountant. Four year later, he joined American International Group, assisting in the business and product development. Subsequently, he had the opportunity to venture into the China market where he was involved in business development and infrastructure work. In 1999, he was involved in corporate restructuring for a chemical company in China and gradually became interested in environmental and telecommunication sectors.
David Cheung, Director & Vice President of Corporate Marketing
Mr. Cheung resigned effective July 2004. After finishing his higher education in Great Britain and receiving his MBA in Finance from Lancaster International Business School of Lancaster University, he joined a subsidiary of Costain Construction as a member of its business development team, specializing in the hospitality sector. After returning to Hong Kong, he was involved in several major infrastructures projects, such as hotels, power plants, roads and bridges, as well as heading up a constancy team for re-marketing of French clothing manufacturer in China. Mr. Cheung joined the Emperor Group in 1998 to lead and implement the strategic business management turn around of the Group's hotel and newspaper divisions. Once back in China, he became a consultant to companies in the fine chemical processing, the Internet and the telecommunications sectors.
22
Yuan Long Jeang, Vice President of Engineering/Research & Development
Mr. Jeang resigned effective July 2004. Mr. Jeang holds a PhD in Electrical Engineering from Chen Kung University, Taiwan. He was a professor for 10 years and Chief of Image Processing Research Laboratory of the Kaohsiung Technical University for 10 years. Mr. Jeang was Chief Designer for Taiwan Films Limited where he managed all technical aspects of computer generated effects, composite design, 3D production and computer generated graphics. For the past five years, he worked closely with Dr. Wu designing algorithms for video and data compression, and has developed standards for cellular phone authentication and encryption.
(B) Significant employees - The Company has one significant employee, its president Abraham Pierce.
(C) There are no family relationships between any executive officers or directors who have held or currently hold office with the Registrant.
(D) Daniel Charboneau, the former president and director of the Company (he has since resigned his position in January 2004) was adjudicated bankrupt on August 17, 2004, and was involved in a federal criminal indictment which has now been concluded. Since January 2004, Mr. Charboneau has had absolutely no connection with the Company whatsoever. No other Director, or person nominated to become a Director or Executive Officer, has been involved in bankruptcy, criminal or other legal proceeding during the past five years.
Compliance with Section 16(a) of the Exchange Act
Based solely upon a review of Forms 3 and 4 and amendments thereto furnished to the Registrant pursuant to Section 240.16a-3 during its most recent fiscal year and Form 5 and amendments thereto furnished to the Registrant with respect to the most recent fiscal year, all executive officers and directors of the Company timely filed the reports required under Section 16(a) of the Securities Exchange Act of 1934, as amended.
Item 10 - Executive Compensation
Mr. Pierce received 12,500,000 shares of restricted common stock valued at $1,250 for services rendered to the Company in his capacity as president for each of the years ended December 31, 2005 and 2004.
For the year ending December 31, 2004, Mr. Wu's contract called for cash or stock compensation in the amount of $52,500. Under that contract Mr. Wu was paid zero dollars in cash and the full balance due was accrued.
For the year ending December 31, 2003, Mr. Wu's contract called for cash or stock compensation in the amount of $105,000. Under that contract Mr. Wu was paid zero dollars in cash and 17,000,000 common shares at $0.001 per share valued at $17,000. The balance of $88,000 was accrued.
Directors do not currently receive any cash compensation.
Item 11 - Security Ownership of Certain Beneficial Owners and Management
The following table sets forth the stock ownership of each person known by the Company to be a beneficial owner of five percent (5%) or more of the Company's equity securities, each Director and executive officer individually and all Directors and Officers of the Company as a group. Each person has sole voting and investment power with respect to the shares shown unless otherwise indicated. As of December 31, 2004, there were 111,074,056 shares issued and outstanding.
23
Name & Address Class Amount Shares
of Beneficial Owner Owned Owned Beneficially % of Class
-----------------------------------------------------------------------------
Abraham Pierce Common 1,250,000 11.25%
162 M Homestead Street
Manchester, CT 06040
Daniel E. Charboneau (1) Common -0- 0.0%
215 Central Park Ave.
Hartsdale, NY 10530
John Jiann-Shong Wu (1) Common -0- 0.0%
21 Street, 6 Fl, No.211
Chung-Cheng 4 Road
Kaoshiung, Taiwan
------------------------------------------------------------------------
Total Shares of Officers and 1,250,000 11.25%
Directors as a Group
There are no arrangements either presently or planned that will results in a change of control of the Company.
Item 12 - Certain Relationships and Related Transactions
The Company was indebted to former officers/stockholders in the amount of $636,743 as of December 31, 2005, which includes $424,281 for unpaid salary, $58,200 for research and development expenses, as discussed below, and $154,262 for merchandise purchases and expenses advanced on behalf of the Company. There are no specific terms for repayment. There is also $167,950 owed to Advance Data Information Corporation (“ADI”), a Taiwan corporation owned by a former director/stockholder of the Company for purchases made by the Company. At December 31, 2005, the conversion rate was $0.10 per share. On January 16, 2006 the Board of Directors of the Company voted to reduce the conversion rat of these notes payable to $0.02 per share.
The Company had leased its executive offices and storage facilities from the former president of the Company under a month-to-month operating lease since the Company’s inception. Rent expense was $0 for the years ended December 31, 2005 and 2004, respectively.
Additionally, the Company entered into a consulting agreement with ADI under which the Company shall have exclusive ownership rights to any and all products that are developed as a result of this agreement. The Company issued 200,000 shares of its common stock to Dr. Wu in August 1997, valued at $.15 per share; 333,333 shares in June 1999, valued at $.81 per share; 1,466,667 shares in December 2000, valued at $.11 per share; 2,400,000 shares in March 2002, valued at $.04; and 17,000,000 shares in June 2003, valued at $.001 for services rendered. On February 1, 2005, all of these shares were returned to the Company and retired to treasury as unissued.
24
Item 13 - Exhibits
(A)
FINANCIAL STATEMENTS
(Inception to December 31, 2005)
Independent Auditor's Report
Consolidated Balance Sheet
Consolidated Statement of Income (Loss)
Consolidated Statement of Changes in Stockholders' Equity
Consolidated Statement of Cash Flow
Consolidated Notes to Financial Statement
(B) Exhibits
Rule 13a-14(a)/15d-14(a) Certification | ||
Section 1350 Certification |
25
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The Company’s board of directors reviews and approves audit and permissible non-audit services performed by the authorized independent public accountants as well as the fees charged by the authorized independent public accountants for such services. In its review of non-audit service fees and its appointment of the authorized independent public accountants as the Company's independent accountants, the board of directors considered whether the provision of such services is compatible with maintaining the authorized independent public accountants’ independence. All of the services provided and fees charged by the authorized independent public accountants in 2003 were pre-approved by the board of directors.
Audit Fees
The aggregate fees billed by the authorized independent public accountants for professional services for the audit of the annual financial statements of the Company and the reviews of the financial statements included in the Company's quarterly reports on Form 10-KSB for 2005 and 2004 were $12,000 and 4,500 respectively, net of expenses.
Audit-Related Fees
There were no other fees billed by the authorized independent public accountants during the last two fiscal years for assurance and related services that were reasonably related to the performance of the audit or review of the Company's financial statements and not reported under "Audit Fees" above.
Tax Fees
The aggregate fees billed by the authorized independent public accountants during the last two fiscal years for professional services rendered by the authorized independent public accountants for tax compliance for 2005 and 2004 were $250 and $250, respectively.
All Other Fees
There were no other fees billed by the authorized independent public accountants during the last two fiscal years for products and services provided by authorized independent public accountants.
26
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on behalf by the undersigned, thereunto duly authorized on March 31, 2006.
TotalMed, Inc.
By:/s/ Abraham Pierce
-------------------------------
Abraham Pierce
President and Chief Executive Officer
27